CohBar (CWBR) 10-K2019 FY Annual report

Filed: 12 Mar 20, 4:09pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abroad, abuse, abusive, adequacy, Adipex, advisor, alleging, Alli, aminopeptidase, amylin, antitumor, apelin, autoimmune, BayBio, belief, beloranib, benzphetamine, BIO, Biocom, biology, biotech, Bontril, breakthrough, burden, calcitonin, candidacy, cardiac, caution, cetilistat, chain, Chairman, chemotherapeutic, China, climate, collagen, committed, confidence, considerCOHBARTMto, consolidated, cytoprotection, davalintide, dedicate, desirable, deviation, Didex, diethyoproprion, disaster, disgorgement, downturn, dual, economy, Engle, epithelial, Europe, expert, extreme, facilitate, family, fibroblast, fibrotic, fluid, frontier, furnish, galectin, ghrelin, GIP, globe, Glucagon, gut, idiopathic, immune, immunologic, immunomodulatory, impossible, improper, incretin, inhibitor, injure, insider, interaction, IPF, Jolla, killing, La, latitude, leptin, lipase, lung, mandated, media, melanoma, methionine, misconduct, mitigation, monoamine, mononuclear, nanomolar, newly, Nicotrol, NK, Nontransferable, oncologic, outage, outbreak, pause, pediatric, peripheral, phendimetrazine, phentermine, potency, potent, power, presence, prophylactic, pulmonary, pursuit, quantify, reaction, recordkeeping, recovery, refined, refusal, relinquish, reparative, resource, restitution, reuptake, runway, scleroderma, seizure, shipment, Similarly, smoking, somatostatin, source, Stelic, stemming, Steven, substance, sympathomimetic, syngeneic, tab, temozolomide, Tenuate, tesofensine, therewith, timeframe, toleragen, triple, unfavorable, unmanaged, unremediated, untitled, verification, viable, viewed, warning, weak, weakened, werede, Xenical, XOMA, YY

Removed: analyzed, antagonist, augmented, awarded, Belviq, call, caption, compensate, constant, continuation, convenient, copy, diversity, divisional, EST, estimating, forfeiture, Foundation, Inflation, inspect, installment, loan, mature, Nominating, official, optimize, optimized, OTCQX, owed, paper, placement, practice, preparer, reached, repayment, Room, superior, target, TSX, unit, unvested, Venture, Washington, yielding

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated CWBR transcripts

CWBR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(Subsection (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of CohBar, Inc., a Delaware corporation (the “Company”), do hereby certify that:

To our knowledge, the Annual Report on Form 10-K for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and

The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

March 12, 2020	By:	/s/ Steven Engle
Date		Steven Engle
		Chief Executive Officer
		(Principal Executive Officer)

March 12, 2020	By:	/s/ Jeffrey F. Biunno
Date		Jeffrey F. Biunno
		Chief Financial Officer
		(Principal Financial and Accounting Officer)